spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Healthcare Industry NewsFeed

 HSMN NewsFeed - 10 Feb 2016
Stryker Announces Definitive Agreement to Acquire Synergetics USA, Inc.'s Neuro Portfolio
Devices Orthopaedic Neurosurgery Acquisitions
 HSMN NewsFeed - 10 Feb 2016
Imprimis Pharmaceuticals to Make a Lower Cost Compounded and Customizable Alternative to Thiola(R)
Biopharmaceuticals Urology
 HSMN NewsFeed - 10 Feb 2016
Cocrystal Pharma Announces In-Licensing of CRISPR Cas Technologies for Hepatitis B Virus and Human Papilloma Virus
Biopharmaceuticals Licensing
 HSMN NewsFeed - 10 Feb 2016
Amarantus Receives Orphan Drug Designation From the US FDA for Eltoprazine in the Treatment of Parkinson's Disease Levodopa-Induced Dyskinesia
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 10 Feb 2016
TransEnterix Finalizes FDA Submission Process Related to SurgiBot System 510(k) Application
Devices Surgery FDA
 HSMN NewsFeed - 10 Feb 2016
BD Receives FDA 510(k) Clearance for Diagnostic Device for HIV/AIDS
Devices Diagnostics HIV/AIDS FDA
 HSMN NewsFeed - 9 Feb 2016
Aytu BioScience Announces First Commercial Sales for Company's MiOXSYS(TM) System for Male Infertility
Devices Urology Product Launch
 HSMN NewsFeed - 9 Feb 2016
PhaseRx Strengthens Board of Directors and Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Feb 2016
Amplyx Pharmaceuticals Expands Management Team and Increases Its Series B Financing to $49.2 Million
Biopharmaceuticals Personnel Venture Capital
 HSMN NewsFeed - 9 Feb 2016
CorMatrix Cardiovascular Inc. Receives 510(k) Clearance for its Tyke(TM) Implantable Device for Neonate and Infant Cardiac Tissue Repair
Devices Cardiology FDA
 HSMN NewsFeed - 9 Feb 2016
Alder BioPharmaceuticals Strengthens and Expands Leadership Team Supporting Advancement of ALD403 Toward Future Commercialization
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Feb 2016
UroGen Pharma Strengthens Board of Directors and Senior Management Team
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 9 Feb 2016
LifeWatch(TM) Receives FDA Clearance for Its Continuous Vital Signs Monitoring Service
Devices Monitoring FDA
 HSMN NewsFeed - 8 Feb 2016
Boston Scientific Announces Medicare Will Cover WATCHMAN(TM) Left Atrial Appendage Closure Device
Devices Interventional Cardiology Reimbursement
 HSMN NewsFeed - 8 Feb 2016
Angel Medical Systems Announces FDA Advisory Committee Meeting for Review of the AngelMed Guardian(R) System
Devices Cardiology Monitoring FDA
 HSMN NewsFeed - 8 Feb 2016
Timothy Damadian Named President and CEO of FONAR
Devices Radiology Personnel
 HSMN NewsFeed - 8 Feb 2016
Rubicon Genomics Announces Distribution Agreement with Beckman Coulter Life Sciences for its ThruPLEX(R) Plasma-Seq Kits
Diagnostics Distribution
 HSMN NewsFeed - 8 Feb 2016
Global Blood Therapeutics Announces Changes to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Feb 2016
Supernus Prevails in Oxtellar XR(R) ANDA Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 8 Feb 2016
Sangamo BioSciences Announces FDA Clearance Of Investigational New Drug Application For ZFN-Mediated Genome Editing Treatment Of MPS I
Biopharmaceuticals FDA
 HSMN NewsFeed - 8 Feb 2016
Astellas Names James Robinson President, Americas Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Feb 2016
Via Surgical Ltd., Closes $6M Investment Led by Benslie Investment Group
Devices Surgery Venture Capital
 HSMN NewsFeed - 8 Feb 2016
BMC Medical Co., Ltd Wins Patent Infringement Litigation Against ResMed
Devices Litigation
 HSMN NewsFeed - 8 Feb 2016
Atlas Genetics Gains CE Approval for First Product
Diagnostics Regulatory
 HSMN NewsFeed - 8 Feb 2016
STENTYS initiates the Commercialization of the first Self-Expanding Drug-Eluting stent for the Below-The-Knee Indication
Devices Interventional Product Launch
 HSMN NewsFeed - 8 Feb 2016
CTI BioPharma Provides Update On Investigational Agent Pacritinib
Biopharmaceuticals Oncology
 HSMN NewsFeed - 6 Feb 2016
Prism Medical Announces Appointment of Chief Executive Officer
Devices Personnel
 HSMN NewsFeed - 5 Feb 2016
Amarantus Requests Rare Pediatric Disease Designation from US FDA for MANF in the Treatment of Retinitis Pigmentosa
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 5 Feb 2016
TVA Medical Receives Additional Reimbursement in Germany for the everlinQ(TM) endoAVF System
Devices Interventional Reimbursement
 HSMN NewsFeed - 5 Feb 2016
Novogen Announces Changes to the Board with New Chairman and Deputy Chairman Appointed
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 4 Feb 2016
Phase 3 Study of BLINCYTO(R) (Blinatumomab) Met Primary Endpoint Of Overall Survival In Patients With B-Cell Precursor Acute Lymphoblastic Leukemia
Biopharmaceuticals Oncology
 HSMN NewsFeed - 4 Feb 2016
Amgen Announces Positive Top-Line Results From Phase 3 GAUSS-3 Trial Of Repatha(R) (Evolocumab) In Statin-Intolerant Patients With High Cholesterol
Biopharmaceuticals
 HSMN NewsFeed - 4 Feb 2016
GTCR Announces Third Partnership with Ed Fiorentino to Form TerSera(TM) Therapeutics
Biopharmaceuticals Personnel Venture Capital
 HSMN NewsFeed - 4 Feb 2016
Sigmoid Pharma Announces Acquisition of Freund Pharmatec Ltd.
Biopharmaceuticals Drug Delivery Mergers & Acquisitions
 HSMN NewsFeed - 4 Feb 2016
Cerapedics Announces Publication of Results from Pivotal IDE Clinical Trial of i-FACTOR(TM) Bone Graft in the Cervical Spine
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 4 Feb 2016
Medovex Receives Reimbursement for Its DenerveX Facet Joint Syndrome Treatment in Germany
Devices Orthopaedic Neurosurgery Reimbursement
 HSMN NewsFeed - 4 Feb 2016
GenomeDx Publishes First Study Supporting Use of Decipher Test in Prostate Biopsy
Diagnostics Oncology
 HSMN NewsFeed - 4 Feb 2016
Lion Biotechnologies Names Steven A. Fischkoff Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 4 Feb 2016
Eagle Pharmaceuticals Announces Appointment of Michael Moran as U.S. Head of Sales
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Feb 2016
CollPlant Reports Positive Final Trial Results for Vergenix(TM)STR, Indicated for the Treatment of Tendinopathy
Biopharmaceuticals Regenerative Medicine
 HSMN NewsFeed - 3 Feb 2016
Silk Therapeutics Raises $6 Million In Series A2 Financing
Dermatology Venture Capital
 HSMN NewsFeed - 3 Feb 2016
TapImmune Granted Fast Track Designation by U.S. Food & Drug Administration for its Lead Vaccine TPIV 200 in the Treatment of Ovarian Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 3 Feb 2016
BioDirection, Inc. Closes $4 Million Series B Financing
Devices Diagnostics Neurology Venture Capital
 HSMN NewsFeed - 3 Feb 2016
Maquet Medical Systems USA, A Getinge Group Company Announces Partnership with BIOTRONIK to Distribute Endovascular Medical Devices in United States
Devices Interventional Distribution
 HSMN NewsFeed - 3 Feb 2016
Emmaus Life Sciences Announces Management Promotions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Feb 2016
ProtoStar(TM) Announces the LifeWalker(TM) Upright, a New Medical Walker Designed to Enable Users to Stand Upright and Walk Safer and Longer for Improved Health
Devices Product Launch
 HSMN NewsFeed - 3 Feb 2016
ProMIS Neurosciences announces identification of a second novel therapeutic target for Alzheimer's disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 3 Feb 2016
LAM Therapeutics Closes $40M in Financing and Announces Two Clinical-Stage Programs in Rare Diseases and Cancer
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 3 Feb 2016
First Patient Treated With LC Bead LUMI(TM) Radiopaque Embolic Bead Supported by Philips Live Image Guidance
Devices Interventional Oncology Radiology
 HSMN NewsFeed - 2 Feb 2016
Telesta Therapeutics Receives Complete Response Letter from FDA
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 2 Feb 2016
Potrero Medical Commences NIH-backed PRESCIENT Study of Accuryn(TM) For Early Detection of Critical Illness
Devices Monitoring
 HSMN NewsFeed - 2 Feb 2016
Lupin Launches Generic Glumetza(R) HCI ER Tablets in the US
Biopharmaceuticals Generics Endocrinology Product Launch
 HSMN NewsFeed - 2 Feb 2016
Spero Therapeutics Announces $30 Million Series B Preferred Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 2 Feb 2016
BONESUPPORT(TM) Reports Expansion Of Company's CERAMENT(TM) Drug Eluting Procedure Registry
Devices Orthopaedic
 HSMN NewsFeed - 2 Feb 2016
PharmaMar and Specialised Therapeutics Asia Sign Licensing and Marketing Agreement for APLIDIN(R) (plitidepsin) Covering Several Asian Countries
Biopharmaceuticals Oncology Licensing Distribution
 HSMN NewsFeed - 2 Feb 2016
Collegium Provides Litigation Update
Biopharmaceuticals Litigation
 HSMN NewsFeed - 2 Feb 2016
Neurocrine Announces Initiation of Phase II Clinical Study of VMAT2 Inhibitor Valbenazine in Children and Adolescents with Tourette Syndrome
Biopharmaceuticals Neurology
 HSMN NewsFeed - 2 Feb 2016
Hansen Medical(R) Announces FDA Clearance of the Magellan(TM) Robotic Catheter eKit
Devices Interventional FDA
 HSMN NewsFeed - 2 Feb 2016
Impax Receives Tentative FDA Approval for Generic Version of Vytorin(R) (ezetimibe and simvastatin) Tablets, 10 mg/10 mg, 10 mg/20 mg, 10 mg/40 mg and 10 mg/80 mg
Biopharmaceuticals Generics Cardiology FDA
 HSMN NewsFeed - 2 Feb 2016
Versartis Reports Confirmatory Top-Line Two-Year Data from Ongoing Extension Study of Somavaratan in GHD Children
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 2 Feb 2016
MISSION Therapeutics Raises £60 million to Progress Development of Novel DUB Inhibitors from Innovative Drug Platform
Biopharmaceuticals Oncology Neurology Venture Capital
 HSMN NewsFeed - 1 Feb 2016
Bioness Announces the Publication of StimRouter(TM) Neuromodulation System Clinical Trial
Devices Neurology
 HSMN NewsFeed - 1 Feb 2016
BioPharmX Appoints Marie-Louise Bots as Senior VP of Corporate Development
Biopharmaceuticals Dermatology Personnel
 HSMN NewsFeed - 1 Feb 2016
Mallinckrodt Completes Acquisition Of Three Commercial-Stage, Global Specialty Hemostasis Brands From The Medicines Company
Devices Surgery Acquisitions
 HSMN NewsFeed - 1 Feb 2016
Seno Medical Instruments Appoints Tom Umbel as Chief Executive Officer
Devices Diagnostics Oncology Personnel
 HSMN NewsFeed - 1 Feb 2016
Aoxing Pharma Appoints Dr. James Chen as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Feb 2016
Merial Appoints Susan Sholtis as President, North America
Biopharmaceuticals Veterinary Personnel
 HSMN NewsFeed - 1 Feb 2016
Stryker Announces Definitive Agreement to Acquire Sage Products, LLC from Madison Dearborn Partners for $2.775 Billion
Devices Orthopaedic Neurosurgery Mergers & Acquisitions
 HSMN NewsFeed - 1 Feb 2016
Abbott to Acquire Alere, Becoming Leader in Point of Care Testing and Significantly Advancing Global Diagnostics Presence
Devices Diagnostics Mergers & Acquisitions
 HSMN NewsFeed - 1 Feb 2016
Proteostasis Therapeutics Receives FDA Fast Track Designation for PTI-428 in Patients With Cystic Fibrosis
Biopharmaceuticals FDA
 HSMN NewsFeed - 1 Feb 2016
New Company ProtoStar(TM) Launched to Produce Safer, Next-Generation Assistive Mobility Products Designed to Reduce Fall Risk and Enable Users to Stand Upright and Walk Longer
Devices
 HSMN NewsFeed - 1 Feb 2016
Trovagene Enters into Agreement with FedMed, Inc. and Significantly Expands Patient Access to Its Precision Cancer Monitoring Platform
Diagnostics Oncology
 HSMN NewsFeed - 1 Feb 2016
Dr. Reddy’s Laboratories Receives USFDA Tentative Approval for Zenavod(TM) (doxycycline) Capsules, 40 mg for the Treatment of Rosacea in Adults
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 29 Jan 2016
Helix BioPharma Corp. Announces Appointment of New Directors to the Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 29 Jan 2016
FDA Approves Eisai's Halaven(R) (eribulin mesylate) Injection for the Treatment of Patients with Advanced Liposarcoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 29 Jan 2016
District Court Dismisses Lawsuit Against Accelerate Diagnostics
Diagnostics Litigation
 HSMN NewsFeed - 29 Jan 2016
Merck Receives FDA Approval of ZEPATIER(TM) (elbasvir and grazoprevir) for the Treatment of Chronic Hepatitis C Virus Genotype 1 or 4 Infection in Adults Following Priority Review
Biopharmaceuticals FDA Product Launch
 HSMN NewsFeed - 29 Jan 2016
Allergan Announces Collaboration with AstraZeneca to Develop and Commercialize ATM-AVI (aztreonam and avibactam) for Antibiotic-Resistant Gram-Negative Infections
Biopharmaceuticals Licensing Distribution
 HSMN NewsFeed - 29 Jan 2016
RegeneRx Announces Completion of Patient Enrollment In Phase 2b/3 U.S. Dry Eye Trial
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 29 Jan 2016
Human Regenerative Technologies, LLC (HRT) Announce WoundEx(R) Amniotic Membrane Products Receive Coverage From Novitas Solutions, Inc.
Devices Regenerative Medicine Reimbursement
 HSMN NewsFeed - 29 Jan 2016
Gilead’s John C. Martin, PhD to Assume Role of Executive Chairman of the Board; John F. Milligan, PhD to Be Appointed Chief Executive Officer and Director
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Jan 2016
Biodel Announces Restructuring Update
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Jan 2016
Allergan's Rapastinel Receives FDA Breakthrough Therapy Designation for Adjunctive Treatment of Major Depressive Disorder (MDD)
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 29 Jan 2016
Viacoram(R) now approved in Canada as a new first line treatment in hypertension
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 28 Jan 2016
Cynata Receives Favourable Advice from UK Regulatory Authority
Regenerative Medicine Regulatory
 HSMN NewsFeed - 28 Jan 2016
New Bladderscan(R) Prime Portable Ultrasound Instrument Redefines Accuracy and Makes Ease-of-Use Easier Than Ever
Devices Urology Product Launch
 HSMN NewsFeed - 28 Jan 2016
Neos Therapeutics Announces FDA Approval of Adzenys XR-ODT(TM) (Amphetamine Extended-Release Orally Disintegrating Tablet) for the Treatment of ADHD in Patients 6 Years and Older
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 28 Jan 2016
DECN Assesses Its Recent Landmark Legal Victories Over Diabetes Division Of Johnson & Johnson
Devices Diagnostics Litigation
 HSMN NewsFeed - 28 Jan 2016
Boston Scientific and Accenture Develop Data-Driven Digital Health Solution to Help Improve Patient Outcomes and Reduce Cost of Treating Chronic Cardiovascular Conditions
Devices
 HSMN NewsFeed - 28 Jan 2016
Venetoclax Receives 3rd Breakthrough Therapy Designation from the FDA for the Combination Treatment of Patients with Untreated Acute Myeloid Leukemia not Eligible for Standard Induction Chemotherapy
Biopharmaceuticals Oncology FDA
More stories   Return to NewsFeed  
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!